Castle Biosciences (CSTL) Prepaid Assets (2018 - 2026)

Castle Biosciences has disclosed Prepaid Assets across 9 years of filings, most recently posting $15.4 million for Q2 2026.

• In Q2 2026, Prepaid Assets rose 27.47% year-over-year to $15.4 million; the TTM figure through Jun 2026 stood at $15.4 million (up 27.47% YoY), while the FY2025 annual figure was $8.0 million, up 3.72% from the prior year.
• Prepaid Assets came in at $15.4 million for Q2 2026 at Castle Biosciences, up from $14.5 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $15.4 million in Q2 2026 to a low of $5.2 million in Q1 2022.
• Average Prepaid Assets over 5 years is $8.4 million, with a median of $6.9 million recorded in 2023.
• Year-over-year, Prepaid Assets fell 8.47% in 2024 and surged 79.59% in 2025.
• Over 5 years, Prepaid Assets stood at $6.2 million in 2022, then climbed by 1.37% to $6.3 million in 2023, then grew by 21.92% to $7.7 million in 2024, then climbed by 3.72% to $8.0 million in 2025, then jumped by 93.24% to $15.4 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $15.4 million in Q2 2026, $14.5 million in Q1 2026, and $8.0 million in Q4 2025.